Proof‐of‐concept trial of PP‐01 for mitigating cannabis withdrawal syndrome in participants with cannabis use disorder
PleoPharma, Inc.
Aug 28
1 min read
top of page
Search
Recent Posts
See AllPP-01 Reduced Symptoms of Cannabis Withdrawal in a Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Clinical Trial
bottom of page